SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-001597
Filing Date
2017-01-04
Accepted
2017-01-04 20:21:02
Documents
2
Period of Report
2017-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2270
2 POA DOCUMENT poa.txt EX-24.3_692756 3775
  Complete submission text file 0001209191-17-001597.txt   7419
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
ProNAi Therapeutics Inc (Issuer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARBUTUS BIOPHARMA CORP. 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
Kowalski Mark (Reporting) CIK: 0001628357 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37490 | Film No.: 17508319